Concepedia

Publication | Open Access

Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease

DOIFull Paper Access

197

Citations

21

References

2022

Year

Susanne Ostrowitzki, Tobias Bittner, Kaycee M. Sink, Howard Mackey, Christina Rabe, Lawrence S. Honig, Emanuele Cassetta, Merçé Boada, Christopher H. van Dyck, Timo Grimmer,
JAMA Neurology

Abstract

ClinicalTrials.gov Identifiers: CREAD, NCT02670083; CREAD2, NCT03114657.

References

YearCitations

Page 1